Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 55.95

-0.6%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: keokalani'nui who wrote (8352)	5/13/2003 8:48:22 PM
From: Biomaven	Read Replies (1) of 52153

Well that was just a denial of a summary judgment motion - not really that surprising. Of course Lilly may yet just chicken out and settle for a 2% royalty, but I bet they don't. I still have to believe that this suit by ARIA is a long shot. Hell, if they win they'll go after aspirin next. (Not really of course, because it's off patent, but I wouldn't be surprised if some aspect of aspirin's mode of action is via NF-(kappa)B.) Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next